78703-57-8

Upstream product

• 25016-12-0 1,3-dimethyl-1H-pyrazole-4-carbaldehyde 
• 78703-53-4 1,3-dimethyl-1H-pyrazole-4-carboxylic acid 
• 78703-55-6 methyl 1,3-dimethyl-1H-pyrazole-4-carboxylate 

Downstream Products

• 861660-35-7 1,3-dimethyl-5-(p-methoxyphenyl)ethynylpyrazole-4-carboxylic acid methyl ester 
• 861660-36-8 1,3-dimethyl-5-(p-methoxyphenyl)ethynylpyrazole-4-carboxylic acid hydrazide 
• 1127237-30-2 13-cyclohexyl-3-methoxy-6-[4-(methoxycarbonyl)-1,3-dimethyl-1H-pyrazol-5-yl]-7H-indolo[2,1-a][2]benzazepine-10-carboxylic acid 1,1-dimethylethyl ester 
• 78703-61-4 1,3-Dimethyl-6-phenyl-1H-pyrano[4,3-c]pyrazol-4-one 

Relevant academic research and scientific papers

COMPOUNDS FOR THE TREATMENT OF HEPATITIS C

The invention encompasses selected compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.

COMPOUNDS FOR THE TREATMENT OF HEPATITIS C

The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.